Efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: a systematic review and meta-analysis

BACKGROUND: The efficacy of selective serotonin reuptake inhibitors (SSRIs) in the treatment of acute COVID-19 is still under investigation, with conflicting results reported from randomized controlled trials (RCTs). Different dosing regimens may have contributed to the contradictory findings. OBJEC...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Jiawen, Rayner, Daniel, Ramaraju, Harikrishnaa B., Abbas, Umaima, Garcia, Cristian, Heybati, Kiyan, Zhou, Fangwen, Huang, Emma, Park, Ye-Jean, Moskalyk, Myron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841740/
https://www.ncbi.nlm.nih.gov/pubmed/36657488
http://dx.doi.org/10.1016/j.cmi.2023.01.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841740/
https://www.ncbi.nlm.nih.gov/pubmed/36657488
http://dx.doi.org/10.1016/j.cmi.2023.01.010

Ejemplares similares